Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN PR vs OxyPR on Gut Microbiota in Chronic Pain
NCT01915147Phase 2Completed
- Sponsor
- Mundipharma
- Start
- Jul 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxycodone + naloxone in chronic pain, opioid-induced constipation (OIC), sponsored by Mundipharma. Started Jul 2013; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
chronic painopioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01915147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01915147.